Aurlide
Pre-clinicalWe are here to identify your first hit molecules. Using Aurlide’s proprietary technology for vHTS, the hit rate for identifying the first-in-class molecule is very high.
Founded
2018
Focus
Drug DeliverySmall Molecules
About
We are here to identify your first hit molecules. Using Aurlide’s proprietary technology for vHTS, the hit rate for identifying the first-in-class molecule is very high.
Company Info
TypePrivate
Founded2018
LocationTurku, Finland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile